Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Casein Kinase
    (21)
  • Apoptosis
    (11)
  • Dopamine Receptor
    (7)
  • Endogenous Metabolite
    (7)
  • 5-HT Receptor
    (6)
  • AChR
    (6)
  • GSK-3
    (6)
  • Monoamine Oxidase
    (6)
  • iGluR
    (6)
  • Others
    (131)
Filter
Search Result
Results for "

neurodegenerative

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    346
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    10
    TargetMol | Compound_Libraries
  • Peptide Products
    14
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    3
    TargetMol | Dye_Reagents
  • PROTAC Products
    3
    TargetMol | PROTAC
  • Natural Products
    40
    TargetMol | Natural_Products
  • Recombinant Protein
    26
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Disease Modeling
    2
    TargetMol | Disease_Modeling_Products
  • Cell Research
    3
    TargetMol | Inhibitors_Agonists
DSRM-3716
T886058142-99-7
Isoquinoline, 5-iodo- is a potent and selective inhibitor of SARM1(IC50 = 75 nM) by preventing axonal degeneration and by allowing functional recovery of a metastable pool of damaged, but viable, axons.
  • $45
In Stock
Size
QTY
Obtusin
TN200470588-05-5
Obtusin is a natural product.
  • $42
In Stock
Size
QTY
β-N-methylamino-L-alanine hydrochloride
L-BMAA hydrochloride
T2291116012-55-8
β-N-Methylamino-L-alanine hydrochloride (L-BMAA hydrochloride) is a neurotoxin produced by cyanobacteria that may contribute to the development of amyotrophic lateral sclerosis (ALS) and possibly other neurodegenerative diseases.
  • $53
In Stock
Size
QTY
(-)-Huperzine A
Huperzine A, HupA
T3026102518-79-6
(-)-Huperzine A (HupA) , an active Lycopodium alkaloid extracted from the traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD).
  • $43
In Stock
Size
QTY
alsterpaullone
T7426237430-03-4
Alsterpaullone is a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells Through Apoptosis-Inducing Effec
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Vasicinone
TC0039486-64-6
Vasicinone may act as a hepatoprotective agent. (±)-Vasicinone has significant antitussive, expectorant, and bronchodilating activities, which can be used to treat respiratory disease.(S)-Vasicinone exhibits antiproliferative activity against human gastric cancer cells MCG-803.
  • $89
In Stock
Size
QTY
Lignoceric Acid
tetracosanoic acid
TN6953557-59-5
Lignoceric Acid (tetracosanoic acid) is a 24-carbon saturated (24:0) fatty acid and a by-product of lignin production, which is synthesized in the developing brain.
  • $41
In Stock
Size
QTY
Neurodegenerative Disorder-Targeting Compound 1
T134861254698-39-9
Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor [1].
  • $1,520
8-10 weeks
Size
QTY
(Rac)-Neurodegenerative Disorder-Targeting Compound 1
T835271254699-12-1
(Rac)-Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor.
  • Inquiry Price
8-10 weeks
Size
QTY
DCPLA-ME
Methyl 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoate, Methyl 8-(2-((2-pentylcyclopropyl)methyl)cyclopropyl)octanoate, DCPLA methyl ester, 2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester
T1098056687-67-3In house
DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative diseases. It is an effective PKCε activator.
  • $59
In Stock
Size
QTY
TargetMol | Inhibitor Hot
VBIT-4
T132872086257-77-2
VBIT-4 is a voltage-dependent anion channel 1 (VDAC1) oligomerization inhibitor (Kd: 17 μM). VBIT-4 can be used for therapeutic purposes in apoptosis-associated disorders (such as neurodegenerative and cardiovascular diseases).
  • $88
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TREM2 agonist-2
T627502738485-98-6In house
TREM2 agonist-2 (I-192) is an orally active and potent agonist of myeloid triggered receptor 2 (TREM2) for neurodegenerative disease research.
  • $283 TargetMol
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Dehydronitrosonisoldipine
T1099187375-91-5In house
Dehydronitrosonisoldipine is an inhibitor of sterile α and TIR motif-containing 1 and can be used in studies about neurodegenerative disorders. Dehydronitrosonisoldipine inhibits axon degenration and the Vincristine-activated cADPR production in neurons.
  • $48
In Stock
Size
QTY
Paliroden
SR 57667
T16430188396-77-2In house
Paliroden is a non-peptide compound that can be taken orally and is used for supplementing neuro-nutrition. It stimulates the synthesis of endogenous neurotrophic factors and is employed in the research of neurodegenerative diseases such as Alzheimer's and Parkinson's.
  • $548
In Stock
Size
QTY
SIB 1553A
T16881L191611-76-4In house
SIB 1553A is an orally available and selective agonist of nicotinic acetylcholine receptors (nAChRs), which are subtype-selective ligands for nicotinic acetylcholine receptors.SIB-1553A is a cognitive enhancer that may be used in the study of neurodegenerative-related diseases such as Alzheimer's disease.
  • $195
In Stock
Size
QTY
VU0359595
VU0359595-1, ML-270, CID-53361951
T217771246303-14-9In house
VU0359595 (ML-270) is a potent and selective pharmacological phospholipase D1 (PLD1) inhibitor with an IC50 of 3.7 nM. VU0359595 is >1700-fold selective for PLD1 over PLD2 (IC50 of 6.4 μM). VU0359595 can be used for the research of cancer, diabetes, neurodegenerative and inflammatory diseases.
  • $81
In Stock
Size
QTY
TCS HDAC6 20b
HDAC6-IN-7
T22159956154-63-5In house
TCS HDAC6 20b (HDAC6-IN-7) is a selective HDAC6 inhibitor that blocks the growth of breast cancer cells and may be used in the study of cancer and neurodegenerative diseases.
  • $182
In Stock
Size
QTY
BrBzGCp2
S-p-Bromobenzylglutathione cyclopentyl diester, pBrBzGSH(Cp)2, p BrBzGSH(Cp)2, BBGD, BBGC
T24598166038-00-2In house
BrBzGCp2 (p BrBzGSH(Cp)2) is an inhibitor of glyoxalase 1 (GLO1) with antitumor and neuroprotective activity. It can alleviate anxiety and be used in neurodegenerative disease research.
  • $158
In Stock
Size
QTY
GSK-239512
GSK239512, GSK 239512
T27462720691-69-0In house
GSK-239512 is an antagonist of H3 receptor and can be used in studies about the treatment of cognitive dysfunction in neurodegenerative disorders.
  • $39
In Stock
Size
QTY
SSR180711 hydrochloride
SSR-180711A HCl, SSR-180711C HCl, SR-180711 HCl
T28856446031-79-4In house
SSR180711 hydrochloride (SSR-180711A HCl) is a selective Alpha7 nicotinic acetylcholine partial agonist for the study of neurodegenerative and cognitive disorders.
  • $30
In Stock
Size
QTY
Anticonvulsant agent 10 HCl
T39252L1818253-48-3In house
5-[(1S,2S)-2-[(Cyclopropylmethyl)amino]cyclopropyl]-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide hydrochloride is a cyclopropanoid enzyme compound that acts as a lysine-specific demethylase-1 inhibitor for schizophrenia, developmental disorders, and neurodegenerative diseases.
  • $195
In Stock
Size
QTY
ZT-1a
T39566212135-62-1In house
ZT-1a is a SPAK inhibitor.ZT-1a inhibits SPAK.ZT-1a can be used for the prevention and treatment of neurodegenerative and neurocognitive disorders.
  • $78
In Stock
Size
QTY
Sinbaglustat
Sinbaglustat, OGT2378, ACT-519276
T40542441061-33-2In house
Sinbaglustat (OGT2378) (OGT2378) is a dual inhibitor of glucose ceramide synthetase (GCS) and non-lysosomal glucose ceramidase (GBA2).Sinbaglustat is an orally administered N-alkyl iminosugar that crosses the blood-brain barrier.Sinbaglustat is used for the treatment of lysosomal storage disorders and for the study of central neurodegenerative disorders associated with lysosomal dysfunction. Sinbaglustat is used for the treatment of lysosomal storage disorders and for the study of lysosomal dysfunction-related central neurodegenerative diseases.
  • $66
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ERD03
ERD 03
T610721377897-01-2In house
ERD03 is a selective compound targeting EXOSC3, disrupting EXOSC3-RNA interactions in a concentration-dependent manner, useful in brain neurodegenerative disease research.
  • $163
In Stock
Size
QTY